Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

Effects of modafinil and R-modafinil on brain stimulation reward thresholds: implications for their use in the treatment of psychostimulant dependence.

Burrows BT, Watterson LR, Johnson MA, Olive MF.

J Drug Alcohol Res. 2015 Dec;4. pii: 235958. Epub 2015 Dec 29.

2.

Pharmacological Neuroenhancement in the Field of Economics-Poll Results from an Online Survey.

Dietz P, Soyka M, Franke AG.

Front Psychol. 2016 Apr 19;7:520. doi: 10.3389/fpsyg.2016.00520. eCollection 2016.

3.

Modafinil Moderates the Relationship Between Cancer-Related Fatigue and Depression in 541 Patients Receiving Chemotherapy.

Conley CC, Kamen CS, Heckler CE, Janelsins MC, Morrow GR, Peppone LJ, Scalzo AJ, Gross H, Dakhil S, Mustian KM, Palesh OG.

J Clin Psychopharmacol. 2016 Feb;36(1):82-5. doi: 10.1097/JCP.0000000000000442.

PMID:
26658264
4.

Congenital and childhood myotonic dystrophy: Current aspects of disease and future directions.

Ho G, Cardamone M, Farrar M.

World J Clin Pediatr. 2015 Nov 8;4(4):66-80. doi: 10.5409/wjcp.v4.i4.66. eCollection 2015 Nov 8. Review.

5.

The dopamine imbalance hypothesis of fatigue in multiple sclerosis and other neurological disorders.

Dobryakova E, Genova HM, DeLuca J, Wylie GR.

Front Neurol. 2015 Mar 12;6:52. doi: 10.3389/fneur.2015.00052. eCollection 2015. Review.

6.

Shared genetic variance between obesity and white matter integrity in Mexican Americans.

Spieker EA, Kochunov P, Rowland LM, Sprooten E, Winkler AM, Olvera RL, Almasy L, Duggirala R, Fox PT, Blangero J, Glahn DC, Curran JE.

Front Genet. 2015 Feb 13;6:26. doi: 10.3389/fgene.2015.00026. eCollection 2015.

7.

Psychostimulants and cognition: a continuum of behavioral and cognitive activation.

Wood S, Sage JR, Shuman T, Anagnostaras SG.

Pharmacol Rev. 2013 Dec 16;66(1):193-221. doi: 10.1124/pr.112.007054. Print 2014. Review.

8.

Efficacy of modafinil on fatigue and excessive daytime sleepiness associated with neurological disorders: a systematic review and meta-analysis.

Sheng P, Hou L, Wang X, Wang X, Huang C, Yu M, Han X, Dong Y.

PLoS One. 2013 Dec 3;8(12):e81802. doi: 10.1371/journal.pone.0081802. eCollection 2013. Review.

9.

Adding to the burden: gastrointestinal symptoms and syndromes in multiple sclerosis.

Levinthal DJ, Rahman A, Nusrat S, O'Leary M, Heyman R, Bielefeldt K.

Mult Scler Int. 2013;2013:319201. doi: 10.1155/2013/319201. Epub 2013 Sep 17.

10.

Agonist replacement for stimulant dependence: a review of clinical research.

Stoops WW, Rush CR.

Curr Pharm Des. 2013;19(40):7026-35. Review.

11.

Jet lag in athletes.

Lee A, Galvez JC.

Sports Health. 2012 May;4(3):211-6.

12.

The FIBRO System: A Rapid Strategy for Assessment and Management of Fibromyalgia Syndrome.

Boomershine CS.

Ther Adv Musculoskelet Dis. 2010 Aug;2(4):187-200. doi: 10.1177/1759720X10374437.

13.

Vincristine-induced unilateral ptosis with serendipitous response to modafinil.

Revannasiddaiah S, Bhattacharyya T.

BMJ Case Rep. 2011 May 3;2011. pii: bcr0720103178. doi: 10.1136/bcr.07.2010.3178.

14.

Apathy syndrome treated successfully with modafinil.

Camargos EF, Quintas JL.

BMJ Case Rep. 2011 Nov 15;2011. pii: bcr0820114652. doi: 10.1136/bcr.08.2011.4652.

15.

Practical use and risk of modafinil, a novel waking drug.

Kim D.

Environ Health Toxicol. 2012;27:e2012007. doi: 10.5620/eht.2012.27.e2012007. Epub 2012 Feb 22.

16.

Pharmacotherapeutics directed at deficiencies associated with cocaine dependence: focus on dopamine, norepinephrine and glutamate.

Haile CN, Mahoney JJ 3rd, Newton TF, De La Garza R 2nd.

Pharmacol Ther. 2012 May;134(2):260-77. doi: 10.1016/j.pharmthera.2012.01.010. Epub 2012 Jan 31. Review.

17.

Modulation of fronto-cortical activity by modafinil: a functional imaging and fos study in the rat.

Gozzi A, Colavito V, Seke Etet PF, Montanari D, Fiorini S, Tambalo S, Bifone A, Zucconi GG, Bentivoglio M.

Neuropsychopharmacology. 2012 Feb;37(3):822-37. doi: 10.1038/npp.2011.260. Epub 2011 Nov 2.

18.
20.

Psychopathology in multiple sclerosis: diagnosis, prevalence and treatment.

Haussleiter IS, BrĂ¼ne M, Juckel G.

Ther Adv Neurol Disord. 2009 Jan;2(1):13-29. doi: 10.1177/1756285608100325.

Items per page

Supplemental Content

Write to the Help Desk